Zeltiq Aesthetics (ZLTQ) 27.49 $ZLTQ
Why Investors Love These Medical Appliances & Equipment's Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical
PR Newswire - Wed Jun 22, 6:45AM CDT
Growth is expected for the U.S. Medical Appliances and Equipment industry as demand for healthcare continues to rise. In today's pre-market research, Stock-Callers.com shifts its attention on these four equities for investors' close review: Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Amedica Corp. (NASDAQ: AMDA), and Nxstage Medical Inc. (NASDAQ: NXTM). Learn more about these stocks and receive your complimentary trade alerts at:
NXTM: 19.78 (+0.40), ZLTQ: 27.49 (+0.46), ALGN: 81.62 (+1.20), AMDA: 1.39 (+0.03)
5 Toxic Stocks to Discard from Your Portfolio Right Now
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 7:27AM CDT
Identifying toxic stocks on a regular basis and removing them from one's portfolio is a secret to investing success.
VRTX: 87.01 (+1.79), ZLTQ: 27.49 (+0.46), ULTI: 209.46 (+0.49), LGF: 21.38 (+0.83), CRM: 82.03 (+1.41)
ZELTIQ Aesthetics, Inc. to Present at Two Upcoming Conferences
Marketwired - Tue May 31, 3:01PM CDT
PLEASANTON, CA --(Marketwired - May 31, 2016) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Taylor Harris, Senior Vice President and Chief Financial Officer, are scheduled to present at two upcoming conferences. The first presentation will be at the Goldman Sachs 37th Annual Global Healthcare Conference in Rancho Palos Verdes, CA.
ZLTQ: 27.49 (+0.46)
Zeltiq reports 1Q loss
Automated Insights - Tue May 10, 3:25PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported a loss of $9.9 million in its first quarter.
ZLTQ: 27.49 (+0.46)
ZELTIQ Announces First Quarter 2016 Financial Results
Marketwire Canada - Tue May 10, 3:01PM CDT
Increases Revenue Guidance to a Range of $320 Million to $325 Million; Received FDA Clearance to Treat Fat Around Bra Straps, on the Back and Underneath the Buttocks; Launched CoolAdvantage(TM) Family of Applicators With 35 Minute Treatment Times; North America Account Utilization up 26% Year-over-Year
ZLTQ: 27.49 (+0.46)
NovaBay Pharmaceuticals Appoints Todd Zavodnick to its Board of Directors
BusinessWire - Mon May 09, 3:30PM CDT
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its Avenova(R) lid and lash hygiene product for the domestic eye care market, announces the appointment of Todd Zavodnick to its Board of Directors, effective May 6, 2016. Mr. Zavodnick brings extensive senior management and commercial experience in the medical technology and pharmaceutical industries, including serving in a senior capacity at the global ophthalmology company Alcon Laboratories. Mr. Zavodnick will serve on the Audit and Nominating and Corporate Governance committees and replaces Massimo Radaelli, Ph.D., who resigned as a Director of NovaBay effective May 6, 2016. NovaBay's Board membership remains at eight.
ZLTQ: 27.49 (+0.46), NBY: 2.65 (+0.15)
Medical Stocks' Q1 Earnings Releases on May 10: ICUI, ZLTQ
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:44AM CDT
The two popular names in the medical space, gearing up to report results on May 10, are ICUI and ZLTQ.
ICUI: 106.79 (+1.81), ZLTQ: 27.49 (+0.46)
Hospira President, David J. Endicott, Joins ZELTIQ Aesthetics Board of Directors
Marketwired - Tue Apr 26, 8:04AM CDT
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced David J. Endicott has joined its Board of Directors.
ZLTQ: 27.49 (+0.46)
Award-Winning CoolSculpting(R) Procedure Now FDA-Cleared to Reduce Fat Around Bra Straps, on the Back and Underneath the Buttocks
Marketwired - Tue Apr 05, 8:03AM CDT
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that it received an expanded clearance from the U.S. Food and Drug Administration (FDA) for the treatment of visible fat bulges of bra fat, back fat and underneath the buttocks (also known as banana roll). The CoolSculpting® procedure is already FDA-cleared for treatment of the double chin (submental area), thigh, abdomen and love handles (flank).
ZLTQ: 27.49 (+0.46)
ZELTIQ to Present at the 28th Annual ROTH Conference
Marketwired - Wed Mar 09, 3:01PM CST
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the 28th Annual ROTH Conference in Laguna Niguel, CA.
ZLTQ: 27.49 (+0.46)
ZELTIQ(R) Launches 3-in-1 CoolAdvantage(TM) Applicator for the CoolSculpting(R) System at American Academy of Dermatology Annual Meeting
Marketwired - Thu Mar 03, 8:02AM CST
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced the launch of a new family of applicators called CoolAdvantage(TM) at the American Academy of Dermatology (AAD) Annual Meeting in Washington, D.C., March 4-8, 2016. The CoolAdvantage applicator delivers the proprietary CoolSculpting® cooling technology at a lower temperature, reducing treatment time nearly in half, and features an adaptable 3-in-1 configuration and enhanced cup design.
ZLTQ: 27.49 (+0.46)
What's in the Cards for Ecolab (ECL) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Fri Feb 19, 1:25PM CST
Ecolab Inc. (ECL) is set to report fourth-quarter 2015 results on Feb 23.
ZLTQ: 27.49 (+0.46), GWPH: 88.11 (-0.46), HOLX: 35.32 (+1.21), ECL: 120.90 (+1.46)
Citizens Financial to join the S&P 500
M2 - Wed Feb 03, 7:40AM CST
S&P Dow Jones Indices has reported it will replace Precision Castparts Corp. (NYSE: PCP) with Citizens Financial Group Inc. (NYSE: CFG) in the S&P 500 after the close of trading on Friday, January 29, the company said. S&P 100 & 500 constituent Berkshire Hathaway Inc. (NYSE: BRK.
is acquiring Precision Castparts in a deal expected to be completed on or about that date pending final conditions. ZELTIQ Aesthetics Inc. (NASD:ZLTQ) will replace MedAssets Inc. (NASD:MDAS) in the S&P SmallCap 600 after the close of trading on Friday, January 29. Private equity firm Pamplona Capital Management is acquiring MedAssets in a deal expected to be completed soon pending final conditions. RE/MAX Holdings Inc. (NYSE: RMAX) will replace The Pep Boys--Manny, Moe & Jack (NYSE: PBY) in the S&P SmallCap 600 after the close of trading on Tuesday, February 2. Icahn Enterprises L.P. (NASD:IEP) is acquiring Pep Boys in a deal expected to be completed soon pending final conditions. Citizens Financial Group provides retail and commercial banking products and services. ZELTIQ Aesthetics is a medical technology company. RE/MAX Holdings operates as a franchisor of residential and commercial real estate brokerage services. S&P Dow Jones Indices LLC, a part of McGraw Hill Financial, is a resource for index-based concepts, data and research.
RMAX: 41.76 (-0.07), ZLTQ: 27.49 (+0.46), PBY: 18.50 (+0.01), CFG: 22.00 (+0.63), IEP: 54.51 (+1.07), MDAS: 31.35 (+0.01), MHFI: 107.92 (+1.16), BRK.B: 145.20 (+1.26), PCP: 234.95 (+0.10)
Medical Appliances & Equipment Equities Ahead of Market -- ResMed, ZELTIQ Aesthetics, MiMedx Group, and Varian Medical Systems
ACCESSWIRE - Wed Feb 03, 7:04AM CST
NEW YORK, NY / ACCESSWIRE / February 3, 2016 / Park Lane Advisor has initiated coverage on the following equities: ResMed Inc. (NYSE: RMD), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), MiMedx Group Inc. (NASDAQ: MDXG), and Varian Medical Systems Inc. (NYSE: VAR). Free research report on ResMed can be accessed at http://www.parklaneadvisor.com/ On Tuesday, February 02, 2016, the NASDAQ Composite ended at 4,516.95, down 2.24%, the Dow Jones Industrial Average declined 1.80%, to finish the day at 16,153.54, and the S&P 500 closed at 1,903.03, down 1.87%. Register for your complimentary reports at the links given below.
ZLTQ: 27.49 (+0.46), VAR: 83.79 (+0.71), RMD: 63.38 (+1.05), MDSY: 1.50 (+0.01), MDXG: 7.78 (+0.19)
ZELTIQ to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Marketwired - Thu Jan 28, 3:01PM CST
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the Leerink Partners 5th Annual Global Healthcare Conference New York City.
ZLTQ: 27.49 (+0.46)
Medical Aesthetics Market Forecast to 2020 - Increasing Demand For Minimally Invasive & Non-Invasive Aesthetic Procedures
M2 - Thu Jan 28, 5:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/bd5l42/medical) has announced the addition of the "Medical Aesthetics Market by Products, Procedures, & End-Users - Global Forecast to 2020" report to their offering. The market is expected to reach $12,581.9 Million by 2020, at a CAGR of 10.8% from 2015 to 2020. Factors such as the increasing demand of minimally invasive and non-invasive aesthetic procedures, technological advancements in energy based devices, and rapid growth in number of cosmetic procedures are driving the growth of the global medical aesthetics market. However, stringent safety regulations for aesthetic procedures, and a significant number of product recalls are restricting the growth of the global medical aesthetics market. Geographically, North America (comprising the U.S. and Canada) commanded the largest share of 49.0% of the global medical aesthetics market in 2015, followed by Europe. North America will continue to lead in the years to come, owing to rapidly aging and obese population, technological advancements, and growing FDA approvals of devices in the U.S. The growth of the global medical aesthetics market is mainly driven by the growing adoption of minimally invasive and noninvasive aesthetic procedures, aging population, increasing awareness among customers, technological advancements in energy-based devices, rising number of aesthetic procedures, and increasing demand for aesthetic treatments among the male population. However, a stringent safety regulation for aesthetic procedures is a major factor restraining the growth of this market. Growing adoption of home use aesthetic devices and increasing demand for cosmetic treatments in emerging markets are creating opportunities for growth of the medical aesthetics market. Companies Mentioned: - Allergan, Inc. - Cynosure, Inc. - Galderma S.A. (Switzerland) - Lumenis Ltd. - Mentor Worldwide LLC - PhotoMedex, Inc. - Solta Medical, Inc. - Syneron Medical, Ltd. - ZELTIQ Aesthetics, Inc. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Market, By Product 7 Medical Aesthetics Market, By End User 8 Medical Aesthetics Market, By Procedure 9 Global Medical Aesthetics Market, By Region 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/bd5l42/medical
ELOS: 7.28 (+0.10), AGN: 230.71 (+2.16), ZLTQ: 27.49 (+0.46), CYNO: 47.99 (+0.16), LMNS: 13.76 (+0.04), PHMD: 0.29 (-0.04)
ZELTIQ Added to the S&P SmallCap 600(R) Index
Marketwired - Wed Jan 27, 3:01PM CST
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that the Company has been selected by S&P Dow Jones Indices to join the S&P SmallCap 600 after the close of trading on January 29, 2016.
ZLTQ: 27.49 (+0.46)
Citizens Financial Group Set to Join the S&P 500; ZELTIQ Aesthetics, RE/MAX to Join S&P SmallCap 600
PR Newswire - Tue Jan 26, 5:15PM CST
S&P Dow Jones Indices will make the following changes to the S&P 500 and S&P SmallCap 600 indices:
RMAX: 41.76 (-0.07), ZLTQ: 27.49 (+0.46), PBY: 18.50 (+0.01), CFG: 22.00 (+0.63), IEP: 54.51 (+1.07), MDAS: 31.35 (+0.01), MHFI: 107.92 (+1.16), BRK.B: 145.20 (+1.26), PCP: 234.95 (+0.10)
Why Investors Love These Medical Appliances & Equipment's Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical
PR Newswire - Wed Jun 22, 6:45AM CDT
Growth is expected for the U.S. Medical Appliances and Equipment industry as demand for healthcare continues to rise. In today's pre-market research, Stock-Callers.com shifts its attention on these four equities for investors' close review: Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Amedica Corp. (NASDAQ: AMDA), and Nxstage Medical Inc. (NASDAQ: NXTM). Learn more about these stocks and receive your complimentary trade alerts at:
NXTM: 19.78 (+0.40), ZLTQ: 27.49 (+0.46), ALGN: 81.62 (+1.20), AMDA: 1.39 (+0.03)
5 Toxic Stocks to Discard from Your Portfolio Right Now
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 7:27AM CDT
Identifying toxic stocks on a regular basis and removing them from one's portfolio is a secret to investing success.
VRTX: 87.01 (+1.79), ZLTQ: 27.49 (+0.46), ULTI: 209.46 (+0.49), LGF: 21.38 (+0.83), CRM: 82.03 (+1.41)
ZELTIQ Aesthetics, Inc. to Present at Two Upcoming Conferences
Marketwired - Tue May 31, 3:01PM CDT
PLEASANTON, CA --(Marketwired - May 31, 2016) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Taylor Harris, Senior Vice President and Chief Financial Officer, are scheduled to present at two upcoming conferences. The first presentation will be at the Goldman Sachs 37th Annual Global Healthcare Conference in Rancho Palos Verdes, CA.
ZLTQ: 27.49 (+0.46)
Zeltiq reports 1Q loss
Automated Insights - Tue May 10, 3:25PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported a loss of $9.9 million in its first quarter.
ZLTQ: 27.49 (+0.46)
ZELTIQ Announces First Quarter 2016 Financial Results
Marketwire Canada - Tue May 10, 3:01PM CDT
Increases Revenue Guidance to a Range of $320 Million to $325 Million; Received FDA Clearance to Treat Fat Around Bra Straps, on the Back and Underneath the Buttocks; Launched CoolAdvantage(TM) Family of Applicators With 35 Minute Treatment Times; North America Account Utilization up 26% Year-over-Year
ZLTQ: 27.49 (+0.46)
NovaBay Pharmaceuticals Appoints Todd Zavodnick to its Board of Directors
BusinessWire - Mon May 09, 3:30PM CDT
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its Avenova(R) lid and lash hygiene product for the domestic eye care market, announces the appointment of Todd Zavodnick to its Board of Directors, effective May 6, 2016. Mr. Zavodnick brings extensive senior management and commercial experience in the medical technology and pharmaceutical industries, including serving in a senior capacity at the global ophthalmology company Alcon Laboratories. Mr. Zavodnick will serve on the Audit and Nominating and Corporate Governance committees and replaces Massimo Radaelli, Ph.D., who resigned as a Director of NovaBay effective May 6, 2016. NovaBay's Board membership remains at eight.
ZLTQ: 27.49 (+0.46), NBY: 2.65 (+0.15)
Medical Stocks' Q1 Earnings Releases on May 10: ICUI, ZLTQ
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:44AM CDT
The two popular names in the medical space, gearing up to report results on May 10, are ICUI and ZLTQ.
ICUI: 106.79 (+1.81), ZLTQ: 27.49 (+0.46)
Hospira President, David J. Endicott, Joins ZELTIQ Aesthetics Board of Directors
Marketwired - Tue Apr 26, 8:04AM CDT
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced David J. Endicott has joined its Board of Directors.
ZLTQ: 27.49 (+0.46)
Award-Winning CoolSculpting(R) Procedure Now FDA-Cleared to Reduce Fat Around Bra Straps, on the Back and Underneath the Buttocks
Marketwired - Tue Apr 05, 8:03AM CDT
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that it received an expanded clearance from the U.S. Food and Drug Administration (FDA) for the treatment of visible fat bulges of bra fat, back fat and underneath the buttocks (also known as banana roll). The CoolSculpting® procedure is already FDA-cleared for treatment of the double chin (submental area), thigh, abdomen and love handles (flank).
ZLTQ: 27.49 (+0.46)
ZELTIQ to Present at the 28th Annual ROTH Conference
Marketwired - Wed Mar 09, 3:01PM CST
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the 28th Annual ROTH Conference in Laguna Niguel, CA.
ZLTQ: 27.49 (+0.46)
ZELTIQ(R) Launches 3-in-1 CoolAdvantage(TM) Applicator for the CoolSculpting(R) System at American Academy of Dermatology Annual Meeting
Marketwired - Thu Mar 03, 8:02AM CST
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced the launch of a new family of applicators called CoolAdvantage(TM) at the American Academy of Dermatology (AAD) Annual Meeting in Washington, D.C., March 4-8, 2016. The CoolAdvantage applicator delivers the proprietary CoolSculpting® cooling technology at a lower temperature, reducing treatment time nearly in half, and features an adaptable 3-in-1 configuration and enhanced cup design.
ZLTQ: 27.49 (+0.46)
What's in the Cards for Ecolab (ECL) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Fri Feb 19, 1:25PM CST
Ecolab Inc. (ECL) is set to report fourth-quarter 2015 results on Feb 23.
ZLTQ: 27.49 (+0.46), GWPH: 88.11 (-0.46), HOLX: 35.32 (+1.21), ECL: 120.90 (+1.46)
Citizens Financial to join the S&P 500
M2 - Wed Feb 03, 7:40AM CST
S&P Dow Jones Indices has reported it will replace Precision Castparts Corp. (NYSE: PCP) with Citizens Financial Group Inc. (NYSE: CFG) in the S&P 500 after the close of trading on Friday, January 29, the company said. S&P 100 & 500 constituent Berkshire Hathaway Inc. (NYSE: BRK.
is acquiring Precision Castparts in a deal expected to be completed on or about that date pending final conditions. ZELTIQ Aesthetics Inc. (NASD:ZLTQ) will replace MedAssets Inc. (NASD:MDAS) in the S&P SmallCap 600 after the close of trading on Friday, January 29. Private equity firm Pamplona Capital Management is acquiring MedAssets in a deal expected to be completed soon pending final conditions. RE/MAX Holdings Inc. (NYSE: RMAX) will replace The Pep Boys--Manny, Moe & Jack (NYSE: PBY) in the S&P SmallCap 600 after the close of trading on Tuesday, February 2. Icahn Enterprises L.P. (NASD:IEP) is acquiring Pep Boys in a deal expected to be completed soon pending final conditions. Citizens Financial Group provides retail and commercial banking products and services. ZELTIQ Aesthetics is a medical technology company. RE/MAX Holdings operates as a franchisor of residential and commercial real estate brokerage services. S&P Dow Jones Indices LLC, a part of McGraw Hill Financial, is a resource for index-based concepts, data and research. RMAX: 41.76 (-0.07), ZLTQ: 27.49 (+0.46), PBY: 18.50 (+0.01), CFG: 22.00 (+0.63), IEP: 54.51 (+1.07), MDAS: 31.35 (+0.01), MHFI: 107.92 (+1.16), BRK.B: 145.20 (+1.26), PCP: 234.95 (+0.10)
Medical Appliances & Equipment Equities Ahead of Market -- ResMed, ZELTIQ Aesthetics, MiMedx Group, and Varian Medical Systems
ACCESSWIRE - Wed Feb 03, 7:04AM CST
NEW YORK, NY / ACCESSWIRE / February 3, 2016 / Park Lane Advisor has initiated coverage on the following equities: ResMed Inc. (NYSE: RMD), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), MiMedx Group Inc. (NASDAQ: MDXG), and Varian Medical Systems Inc. (NYSE: VAR). Free research report on ResMed can be accessed at http://www.parklaneadvisor.com/ On Tuesday, February 02, 2016, the NASDAQ Composite ended at 4,516.95, down 2.24%, the Dow Jones Industrial Average declined 1.80%, to finish the day at 16,153.54, and the S&P 500 closed at 1,903.03, down 1.87%. Register for your complimentary reports at the links given below.
ZLTQ: 27.49 (+0.46), VAR: 83.79 (+0.71), RMD: 63.38 (+1.05), MDSY: 1.50 (+0.01), MDXG: 7.78 (+0.19)
ZELTIQ to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Marketwired - Thu Jan 28, 3:01PM CST
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the Leerink Partners 5th Annual Global Healthcare Conference New York City.
ZLTQ: 27.49 (+0.46)
Medical Aesthetics Market Forecast to 2020 - Increasing Demand For Minimally Invasive & Non-Invasive Aesthetic Procedures
M2 - Thu Jan 28, 5:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/bd5l42/medical) has announced the addition of the "Medical Aesthetics Market by Products, Procedures, & End-Users - Global Forecast to 2020" report to their offering. The market is expected to reach $12,581.9 Million by 2020, at a CAGR of 10.8% from 2015 to 2020. Factors such as the increasing demand of minimally invasive and non-invasive aesthetic procedures, technological advancements in energy based devices, and rapid growth in number of cosmetic procedures are driving the growth of the global medical aesthetics market. However, stringent safety regulations for aesthetic procedures, and a significant number of product recalls are restricting the growth of the global medical aesthetics market. Geographically, North America (comprising the U.S. and Canada) commanded the largest share of 49.0% of the global medical aesthetics market in 2015, followed by Europe. North America will continue to lead in the years to come, owing to rapidly aging and obese population, technological advancements, and growing FDA approvals of devices in the U.S. The growth of the global medical aesthetics market is mainly driven by the growing adoption of minimally invasive and noninvasive aesthetic procedures, aging population, increasing awareness among customers, technological advancements in energy-based devices, rising number of aesthetic procedures, and increasing demand for aesthetic treatments among the male population. However, a stringent safety regulation for aesthetic procedures is a major factor restraining the growth of this market. Growing adoption of home use aesthetic devices and increasing demand for cosmetic treatments in emerging markets are creating opportunities for growth of the medical aesthetics market. Companies Mentioned: - Allergan, Inc. - Cynosure, Inc. - Galderma S.A. (Switzerland) - Lumenis Ltd. - Mentor Worldwide LLC - PhotoMedex, Inc. - Solta Medical, Inc. - Syneron Medical, Ltd. - ZELTIQ Aesthetics, Inc. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Market, By Product 7 Medical Aesthetics Market, By End User 8 Medical Aesthetics Market, By Procedure 9 Global Medical Aesthetics Market, By Region 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/bd5l42/medical
ELOS: 7.28 (+0.10), AGN: 230.71 (+2.16), ZLTQ: 27.49 (+0.46), CYNO: 47.99 (+0.16), LMNS: 13.76 (+0.04), PHMD: 0.29 (-0.04)
ZELTIQ Added to the S&P SmallCap 600(R) Index
Marketwired - Wed Jan 27, 3:01PM CST
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that the Company has been selected by S&P Dow Jones Indices to join the S&P SmallCap 600 after the close of trading on January 29, 2016.
ZLTQ: 27.49 (+0.46)
Citizens Financial Group Set to Join the S&P 500; ZELTIQ Aesthetics, RE/MAX to Join S&P SmallCap 600
PR Newswire - Tue Jan 26, 5:15PM CST
S&P Dow Jones Indices will make the following changes to the S&P 500 and S&P SmallCap 600 indices:
RMAX: 41.76 (-0.07), ZLTQ: 27.49 (+0.46), PBY: 18.50 (+0.01), CFG: 22.00 (+0.63), IEP: 54.51 (+1.07), MDAS: 31.35 (+0.01), MHFI: 107.92 (+1.16), BRK.B: 145.20 (+1.26), PCP: 234.95 (+0.10)
